Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GOLGB1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CR392000.1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | ZNF615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | MANBAL | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | DEGS1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ANKHD1-EIF4EBP3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | FBXL20 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | TUB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | TCERG1L | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | SLC30A5 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |